dc.contributor.author |
Safadi M.A. |
|
dc.contributor.author |
Riera-Montes M. |
|
dc.contributor.author |
Bravo L. |
|
dc.contributor.author |
Tangsathapornpong A. |
|
dc.contributor.author |
Lagos R. |
|
dc.contributor.author |
Thisyakorn U. |
|
dc.contributor.author |
Linhares A.C. |
|
dc.contributor.author |
Capeding R. |
|
dc.contributor.author |
Prommalikit O. |
|
dc.contributor.author |
Verstraeten T. |
|
dc.contributor.author |
O'Ryan M. |
|
dc.date.accessioned |
2022-03-10T13:16:38Z |
|
dc.date.available |
2022-03-10T13:16:38Z |
|
dc.date.issued |
2021 |
|
dc.identifier.issn |
12019712 |
|
dc.identifier.other |
2-s2.0-85110538928 |
|
dc.identifier.uri |
https://ir.swu.ac.th/jspui/handle/123456789/17227 |
|
dc.identifier.uri |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85110538928&doi=10.1016%2fj.ijid.2021.06.037&partnerID=40&md5=1eef88423a611972c45696414f28644e |
|
dc.description.abstract |
Background: Noroviruses (NoVs) cause acute gastroenteritis (AGE) worldwide, affecting children in particular. We aimed to estimate the burden of disease due to NoV among children aged <6 years in Brazil, Chile, Philippines and Thailand. Methods: This was a prospective, hospital-based, observational study. Children were recruited over one year between 2014 and 2017. Four cohorts were analysed: community-acquired AGE outpatients and inpatients, nosocomial AGE inpatients, and asymptomatic outpatients. We collected demographic and clinical data, and a stool sample that was tested for NoV. Positive samples were tested for Rotavirus (RV) and NoV-genotyped. Disease severity was assessed by the Vesikari and modified Vesikari scores. Prevalence and incidence of NoV-AGE were estimated by cohort and country. Results: 1637 participants yielded valid laboratory results. The proportion of NoV-positive cases was 23.8% (95% CI 20.8-27.2) in the outpatient cohort, 17.9% (15.0-21.3) in the hospital cohort, 21.4% (12.7-33.8) in the nosocomial cohort and 9.6% (6.9-13.2) in the asymptomatic cohort. Genotype GII.4 was predominant (58%). Less than 4% samples had RV coinfection. In general, NoV-positive subjects had more severe presentations than NoV-negative subjects. Conclusions: NoV caused AGE with substantial burden throughout the studied settings, with higher relative frequency in Brazil where RV vaccination coverage is high. © 2021 The Authors |
|
dc.language |
en |
|
dc.subject |
acute gastroenteritis |
|
dc.subject |
Article |
|
dc.subject |
asymptomatic infection |
|
dc.subject |
Brazil |
|
dc.subject |
child |
|
dc.subject |
Chile |
|
dc.subject |
clinical feature |
|
dc.subject |
cohort analysis |
|
dc.subject |
coinfection |
|
dc.subject |
community acquired infection |
|
dc.subject |
disease burden |
|
dc.subject |
disease severity assessment |
|
dc.subject |
female |
|
dc.subject |
global disease burden |
|
dc.subject |
hospital infection |
|
dc.subject |
hospital patient |
|
dc.subject |
human |
|
dc.subject |
incidence |
|
dc.subject |
major clinical study |
|
dc.subject |
male |
|
dc.subject |
molecular epidemiology |
|
dc.subject |
nonhuman |
|
dc.subject |
Norovirus |
|
dc.subject |
Norovirus genotype GII.4 |
|
dc.subject |
norovirus infection |
|
dc.subject |
observational study |
|
dc.subject |
outpatient |
|
dc.subject |
Philippines |
|
dc.subject |
prevalence |
|
dc.subject |
prospective study |
|
dc.subject |
Rotavirus infection |
|
dc.subject |
Thailand |
|
dc.subject |
calicivirus infection |
|
dc.subject |
feces |
|
dc.subject |
genetics |
|
dc.subject |
genotype |
|
dc.subject |
infant |
|
dc.subject |
Norovirus |
|
dc.subject |
virus RNA |
|
dc.subject |
Brazil |
|
dc.subject |
Caliciviridae Infections |
|
dc.subject |
Child |
|
dc.subject |
Chile |
|
dc.subject |
Feces |
|
dc.subject |
Genotype |
|
dc.subject |
Humans |
|
dc.subject |
Infant |
|
dc.subject |
Norovirus |
|
dc.subject |
Philippines |
|
dc.subject |
Prospective Studies |
|
dc.subject |
RNA, Viral |
|
dc.subject |
Thailand |
|
dc.title |
The burden of norovirus disease in children: a multi-country study in Chile, Brazil, Thailand and the Philippines |
|
dc.type |
Article |
|
dc.rights.holder |
Scopus |
|
dc.identifier.bibliograpycitation |
International Journal of Infectious Diseases. Vol 109, No. (2021), p.77-84 |
|
dc.identifier.doi |
10.1016/j.ijid.2021.06.037 |
|